The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Screening Tests for Geriatric Depression
Brink, T. L., Yesavage, J. A., Lum, O., Heersema, P. H., Adey, M., & Rose, T. L. (1982) · Clinical Gerontologist · doi:10.1300/j018v01n01_06 · Cited by 1,494
(2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_300379 · Cited by 1,445
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070 · cited 2×
“In addition to direct stimulation of nicotinic receptors, nicotine may provide cascading effects via stimulation of the release of a variety of transmitters involved in cognitive function, including acetylcholine, dopamine, norepinephrine, serotonin, and glutamate (Wonnacott et al. 1989; McGehee et al. 1995).”
BackgroundNicotinic acetylcholine involvement in cognitive function in animals
Levin, E. D., & Simon, B. B. (1998) · Psychopharmacology · doi:10.1007/s002130050667 · Cited by 678
Self-citationA multiple scoring method for the assessment of complex memory functions.
Russell, E. W. (1975) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.43.6.800 · Cited by 625
Sahakian, B., Jones, G., Levy, R., Gray, J., & Warburton, D. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.6.797 · Cited by 494
Cited by
Effects of cigarette smoke on the immune system
Sopori, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri803 · Cited by 1,217
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
“Chronic nicotine skin patches have been used to improve attentiveness in people with mild to moderate Alzheimer’s disease (White and Levin 1999), those with age-associated memory impairment (White and Levin 2004) as well as adults with ADHD (Levin et al.”
BackgroundMethodSelf-citationLevin, E. D., McClernon, F. J., & Rezvani, A. H. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0164-7 · Cited by 820
Self-citationRezvani, A. H., & Levin, E. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01094-5 · Cited by 495
Self-citationEffects of nicotinic stimulation on cognitive performance
Newhouse, P. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 405
Advances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 394
Nicotinic receptor subtypes and cognitive function
Levin, E. D. (2002) · Journal of Neurobiology · doi:10.1002/neu.10151 · Cited by 354
Self-citationSheridan, P. L., & Hausdorff, J. M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000105126 · Cited by 339
Multiple neuronal networks mediate sustained attention
Lawrence, N. S., Ross, T. J., Hoffmann, R., Garavan, H., & Stein, E. A. (2003) · Journal of Cognitive Neuroscience · doi:10.1162/089892903770007416 · Cited by 310
“Deficits in sustained attention may underlie a number of cognitive abnormalities found in neuropsychiatric disorders, such as those in attention deficit hyperactivity disorder (Conners et al., 1996; Levin et al., 1996), Alzheimer’ s disease ( White & Levin, 1999; Jones, Sahakian, Levy, Warburton, & Gray, 1992; Sahakia…”
Grottick, A. J., & Higgins, G. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00305-3 · Cited by 240
Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092313 · Cited by 240
Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors
McKay, B. E., Placzek, A. N., & Dani, J. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.001 · Cited by 181
Drug development for Alzheimer's disease: where are we now and where are we headed?
Sabbagh, M. N. (2009) · The American journal of geriatric pharmacotherapy · doi:10.1016/j.amjopharm.2009.06.003 · Cited by 147
Nicotinic treatment of Alzheimer’s disease
Newhouse, P. A., Potter, A., Kelton, M., & Corwin, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01069-6 · Cited by 146
Dose-Related Enhancement of Mood and Cognition in Smokers Administered Nicotine Nasal Spray
Myers, C. S., Taylor, R. C., Moolchan, E. T., & Heishman, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301425 · Cited by 143
Chen, R., Clifford, A., Lang, L., & Anstey, K. J. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.07.001 · Cited by 142
nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
Sarter, M., Parikh, V., & Howe, W. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.019 · Cited by 123
McClernon, F. J., Hiott, F. B., Westman, E. C., Rose, J. E., & Levin, E. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0516-y · Cited by 106
Self-citationSemenova, S., Stolerman, I. P., & Markou, A. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.009 · Cited by 104
Bacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96
Dunbar, G. C., Inglis, F., Kuchibhatla, R., Sharma, T., Tomlinson, M., & Wamsley, J. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107066855 · Cited by 75
Young, J. W., Meves, J. M., & Geyer, M. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.028 · Cited by 69
Barbier, A. J., Hilhorst, M., Vliet, A. V., Snyder, P., Palfreyman, M. G., Gawryl, M., Dgetluck, N., Massaro, M., Tiessen, R., Timmerman, W., et al. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.09.013 · Cited by 51
“Age, y Mean (SD) 25 (6) 23 (4) 31 (10) 27 (8) 22 (2) 21 (2) 26 (7) Range 19 41 18 31 20 44 20 42 20 26 19 26 20 41 Height, cm Mean (SD) 181 (5) 187 (6) 180 (5) 181 (8) 186 (3) 184 (5) 179 (6) Range 171 188 179 195 174 185 168 193 182 189 177 191 170 189 Weight, kg Mean (SD) 78.”
Differential effects of nicotine exposure on the hippocampus across lifespan
Zeid, D., Kutlu, M. G., & Gould, T. J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170714092436 · Cited by 36
A unifying hypothesis of alzheimer’s disease: III—Risk factors
Heininger, K. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(200001)15:1<1::aid-hup153>3.0.co;2-1
Metadata
- Authors
- White, H. K., & Levin, E. D.
- Venue
- Psychopharmacology
- Published
- 1999-04-01
- Volume
- 143
- Issue
- 2
- Pages
- 158-165
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2070644314
- Cited by
- 273
- References
- 29
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.